RSK2 inactivation cooperates with AXIN1 inactivation or ss-catenin activation to promote hepatocarcinogenesis. Schaeffer S, Gupta B, Calatayud AL, Calderaro J, et al. J Hepatol 2023 May 16:S0168-8278(23)00333-1. doi: 10.1016/j.jhep.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Schaeffer S, Gupta B, Calatayud AL, Calderaro J, et al. RSK2 inactivation cooperates with AXIN1 inactivation or ss-catenin activation to promote hepatocarcinogenesis. J Hepatol 2023 May 16:S0168-8278(23)00333-1. doi: 10.1016/j.jhep.2023.
PMID: 37201672